Cargando…

Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles

Structures of BG505 SOSIP.664 trimer in complex with broadly neutralizing antibodies (bNAbs) have revealed the critical role of trimeric context for immune recognition of HIV-1. Presentation of trimeric HIV-1 antigens on nanoparticles may thus provide promising vaccine candidates. Here we report the...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Linling, de Val, Natalia, Morris, Charles D., Vora, Nemil, Thinnes, Therese C., Kong, Leopold, Azadnia, Parisa, Sok, Devin, Zhou, Bin, Burton, Dennis R., Wilson, Ian A, Nemazee, David, Ward, Andrew B., Zhu, Jiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931238/
https://www.ncbi.nlm.nih.gov/pubmed/27349934
http://dx.doi.org/10.1038/ncomms12041
_version_ 1782440854362783744
author He, Linling
de Val, Natalia
Morris, Charles D.
Vora, Nemil
Thinnes, Therese C.
Kong, Leopold
Azadnia, Parisa
Sok, Devin
Zhou, Bin
Burton, Dennis R.
Wilson, Ian A
Nemazee, David
Ward, Andrew B.
Zhu, Jiang
author_facet He, Linling
de Val, Natalia
Morris, Charles D.
Vora, Nemil
Thinnes, Therese C.
Kong, Leopold
Azadnia, Parisa
Sok, Devin
Zhou, Bin
Burton, Dennis R.
Wilson, Ian A
Nemazee, David
Ward, Andrew B.
Zhu, Jiang
author_sort He, Linling
collection PubMed
description Structures of BG505 SOSIP.664 trimer in complex with broadly neutralizing antibodies (bNAbs) have revealed the critical role of trimeric context for immune recognition of HIV-1. Presentation of trimeric HIV-1 antigens on nanoparticles may thus provide promising vaccine candidates. Here we report the rational design, structural analysis and antigenic evaluation of HIV-1 trimer-presenting nanoparticles. We first demonstrate that both V1V2 and gp120 can be presented in native-like trimeric conformations on nanoparticles. We then design nanoparticles presenting various forms of stabilized gp140 trimer based on ferritin and a large, 60-meric E2p that displays 20 spikes mimicking virus-like particles (VLPs). Particle assembly is confirmed by electron microscopy (EM), while antigenic profiles are generated using representative bNAbs and non-NAbs. Lastly, we demonstrate high-yield gp140 nanoparticle production and robust stimulation of B cells carrying cognate VRC01 receptors by gp120 and gp140 nanoparticles. Together, our study provides an arsenal of multivalent immunogens for HIV-1 vaccine development.
format Online
Article
Text
id pubmed-4931238
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-49312382016-07-12 Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles He, Linling de Val, Natalia Morris, Charles D. Vora, Nemil Thinnes, Therese C. Kong, Leopold Azadnia, Parisa Sok, Devin Zhou, Bin Burton, Dennis R. Wilson, Ian A Nemazee, David Ward, Andrew B. Zhu, Jiang Nat Commun Article Structures of BG505 SOSIP.664 trimer in complex with broadly neutralizing antibodies (bNAbs) have revealed the critical role of trimeric context for immune recognition of HIV-1. Presentation of trimeric HIV-1 antigens on nanoparticles may thus provide promising vaccine candidates. Here we report the rational design, structural analysis and antigenic evaluation of HIV-1 trimer-presenting nanoparticles. We first demonstrate that both V1V2 and gp120 can be presented in native-like trimeric conformations on nanoparticles. We then design nanoparticles presenting various forms of stabilized gp140 trimer based on ferritin and a large, 60-meric E2p that displays 20 spikes mimicking virus-like particles (VLPs). Particle assembly is confirmed by electron microscopy (EM), while antigenic profiles are generated using representative bNAbs and non-NAbs. Lastly, we demonstrate high-yield gp140 nanoparticle production and robust stimulation of B cells carrying cognate VRC01 receptors by gp120 and gp140 nanoparticles. Together, our study provides an arsenal of multivalent immunogens for HIV-1 vaccine development. Nature Publishing Group 2016-06-28 /pmc/articles/PMC4931238/ /pubmed/27349934 http://dx.doi.org/10.1038/ncomms12041 Text en Copyright © 2016, Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
He, Linling
de Val, Natalia
Morris, Charles D.
Vora, Nemil
Thinnes, Therese C.
Kong, Leopold
Azadnia, Parisa
Sok, Devin
Zhou, Bin
Burton, Dennis R.
Wilson, Ian A
Nemazee, David
Ward, Andrew B.
Zhu, Jiang
Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles
title Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles
title_full Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles
title_fullStr Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles
title_full_unstemmed Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles
title_short Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles
title_sort presenting native-like trimeric hiv-1 antigens with self-assembling nanoparticles
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931238/
https://www.ncbi.nlm.nih.gov/pubmed/27349934
http://dx.doi.org/10.1038/ncomms12041
work_keys_str_mv AT helinling presentingnativeliketrimerichiv1antigenswithselfassemblingnanoparticles
AT devalnatalia presentingnativeliketrimerichiv1antigenswithselfassemblingnanoparticles
AT morrischarlesd presentingnativeliketrimerichiv1antigenswithselfassemblingnanoparticles
AT voranemil presentingnativeliketrimerichiv1antigenswithselfassemblingnanoparticles
AT thinnestheresec presentingnativeliketrimerichiv1antigenswithselfassemblingnanoparticles
AT kongleopold presentingnativeliketrimerichiv1antigenswithselfassemblingnanoparticles
AT azadniaparisa presentingnativeliketrimerichiv1antigenswithselfassemblingnanoparticles
AT sokdevin presentingnativeliketrimerichiv1antigenswithselfassemblingnanoparticles
AT zhoubin presentingnativeliketrimerichiv1antigenswithselfassemblingnanoparticles
AT burtondennisr presentingnativeliketrimerichiv1antigenswithselfassemblingnanoparticles
AT wilsoniana presentingnativeliketrimerichiv1antigenswithselfassemblingnanoparticles
AT nemazeedavid presentingnativeliketrimerichiv1antigenswithselfassemblingnanoparticles
AT wardandrewb presentingnativeliketrimerichiv1antigenswithselfassemblingnanoparticles
AT zhujiang presentingnativeliketrimerichiv1antigenswithselfassemblingnanoparticles